LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.65 | 21.74 | 1098 | 3754 | 0.2925 | 0.6951 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.65 | 21.74 | 1201 | 3754 | 0.3199 | 0.7157 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.65 | 21.74 | 9 | 3754 | 0.0024 | -0.1119 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.65 | 21.74 | 1204 | 3754 | 0.3207 | 0.7162 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.62 | 21.74 | 1136 | 4150 | 0.2737 | 0.6856 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.62 | 21.74 | 1227 | 4150 | 0.2956 | 0.7028 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.62 | 21.74 | 9 | 4150 | 0.0022 | -0.1099 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.62 | 21.74 | 1241 | 4150 | 0.2990 | 0.7054 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.59 | 21.74 | 1155 | 4492 | 0.2571 | 0.6762 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.59 | 21.74 | 1251 | 4492 | 0.2785 | 0.6937 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.59 | 21.74 | 13 | 4492 | 0.0029 | -0.0647 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.59 | 21.74 | 1275 | 4492 | 0.2838 | 0.6979 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.56 | 21.74 | 1203 | 4838 | 0.2486 | 0.6731 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.56 | 21.74 | 1295 | 4838 | 0.2676 | 0.6890 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.56 | 21.74 | 22 | 4838 | 0.0045 | 0.0015 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.56 | 21.74 | 1334 | 4838 | 0.2757 | 0.6954 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.53 | 21.74 | 1247 | 5150 | 0.2421 | 0.6709 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.53 | 21.74 | 1320 | 5150 | 0.2563 | 0.6830 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.53 | 21.74 | 29 | 5150 | 0.0056 | 0.0372 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.53 | 21.74 | 1388 | 5150 | 0.2695 | 0.6937 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.50 | 21.74 | 1270 | 5425 | 0.2341 | 0.6666 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.50 | 21.74 | 1335 | 5425 | 0.2460 | 0.6771 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.50 | 21.74 | 29 | 5425 | 0.0053 | 0.0368 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.50 | 21.74 | 1419 | 5425 | 0.2615 | 0.6900 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.48 | 21.74 | 1358 | 5768 | 0.2355 | 0.6712 | MN20160310_N01 | C21 |